ACD440 Gel in Peripheral Neuropathic Pain

Clinical trial NCT05416931 · COMPLETED

Trial details

NCT number: NCT05416931
Sponsor: AlzeCure Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral Neuropathic Pain

Start date: 2022-06-20
Primary completion: 2023-03-10
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.